Target intelligence / Profile preview

HIV-1 tat-vpr overlapping mRNA sequence (HIV-1 tat-vpr mRNA)

Target
HIV-1 tat-vpr mRNA
Molecular classification
Other, mRNA, Viral RNA, Nucleic acid
01

Overview

The HIV-1 tat-vpr overlapping mRNA sequence is a critical genomic region in the Human Immunodeficiency Virus type 1 where the reading frames for the Trans-activator of transcription (Tat) and Viral protein R (Vpr) overlap. In the HXB2 reference genome, this overlap occurs between the 3' end of the vpr gene and the 5' end of the first tat exon (Los Alamos HIV Sequence Database, 2023). Tat is an essential regulatory protein that drastically increases the efficiency of viral transcription by binding to the TAR RNA element, while Vpr is a multifunctional protein that facilitates the nuclear import of the viral pre-integration complex and induces G2 cell cycle arrest in host cells (PubMed: 10644350, PubMed: 11133571). Because this sequence is required for the production of two vital viral proteins, it serves as an attractive target for RNA-based therapeutics such as antisense oligonucleotides and small interfering RNAs (siRNAs) (PubMed: 15103333). By binding to this specific mRNA junction, these agents can trigger RNA interference or steric hindrance, effectively reducing viral replication and slowing disease progression. However, the high mutation rate of HIV-1 poses a significant challenge, as even minor sequence variations can lead to drug resistance and therapeutic failure (PubMed: 12438600). Consequently, drug development efforts focus on identifying highly conserved motifs within this overlapping region to ensure broad efficacy across diverse viral clades.

Other names
HIV-1 tat/vpr overlap regionHIV-1 vpr-tat junctionHIV-1 bicistronic tat-vpr mRNA
02

Mechanism of action

Antisense inhibition and RNA interference-mediated degradation of viral mRNA

03

Biological functions

Cell cycleOtherViral replicationTranscriptional transactivationNuclear import of pre-integration complex
04

Disease associations

Infection
05

Safety considerations

Viral resistance due to high mutation ratesOff-target hybridization to host mRNADelivery-related toxicityPotential for immune activation by synthetic oligonucleotides
06

Interacting drugs

Experimental antisense oligonucleotides

1 more in the full profile.

07

Biomarkers

HIV-1 RNA viral loadCD4+ T-lymphocyte countTat protein levelsVpr protein levels

Beyond the preview

Go deeper on HIV-1 tat-vpr overlapping mRNA sequence (HIV-1 tat-vpr mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 tat-vpr overlapping mRNA sequence (HIV-1 tat-vpr mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call